SCHEMBL25528569

SCHEMBL25528569

CC(=O)COc1cc(Cl)c(Cc2ccc(O)c(-c3cccs3)c2)c(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 7/20 0.50
THRA P10827 6/20 0.50
MAPT P10636 7/20 0.36
TDP1 Q9NUW8 3/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
ALDH1A1 P00352 3/20 0.35
TP53 P04637 2/20 0.35
GAA P10253 2/20 0.35
HPGD P15428 2/20 0.35
POLB P06746 2/20 0.35
ALOX15 P16050 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PPARG P37231 2/20 0.34
PPARA Q07869 1/20 0.34
LMNA P02545 2/20 0.34
PTGES O14684 1/20 0.34
PSMB5 P28074 2/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23003713 0.91 THRB (0.59) THRBTHRAHPGDSMN1; SMN2PPARG
SCHEMBL23003651 0.90 THRB (0.48) THRBTHRAMAPTTDP1MEN1
SCHEMBL25528572 0.85 THRB (0.50) THRBTHRAMAPTALDH1A1RAB9A
SCHEMBL25528706 0.84 THRA (0.57) THRBTHRAALDH1A1HPGDRAB9A
SCHEMBL25528574 0.83 THRB (0.50) THRBTHRAMEN1KMT2AALDH1A1
SCHEMBL25528690 0.82 THRB (0.49) THRBTHRATDP1ALDH1A1TP53
SCHEMBL25528579 0.82 THRA (0.51) THRBTHRAPTGESTMIGD3ADORA2A
SCHEMBL25528580 0.82 THRB (0.51) THRBTHRA
SCHEMBL25528562 0.81 THRA (0.52) THRBTHRA
SCHEMBL25528523 0.80 THRA (0.51) THRBTHRAMAPTGAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667606-B2 Thyromimetics AUTOBAHN THERAPEUTICS, INC. (US) 2023-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667606-B2 Thyromimetics TPO, TSHR, TTR THRB 9/4885THRA 4/4885MAPT 1414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.